August 17, 2026

Does Poor Oral Health Raise Autoimmune Disease Risk?

A study of more than 450,000 participants linked self-reported oral health issues with an increased risk of incident autoimmune diseases, though the investigators cautioned that the findings do not establish causality.

MDSpire News

August 17, 2026

Does Poor Oral Health Raise Autoimmune Disease Risk?

A study of more than 450,000 participants linked self-reported oral health issues with an increased risk of incident autoimmune diseases, though the investigators cautioned that the findings do not establish causality.

MDSpire News

August 14, 2026

DOJ targets alleged $95M wound fraud

Federal prosecutors allege a Nevada physician received illegal kickbacks, bribes, and rebates, billed Medicare for medically unnecessary amniotic wound allografts, and falsified patient records.

MDSpire News

August 10, 2026

FDA Approves Melanoma BRAF Companion Test

The assay is indicated to identify patients with advanced melanoma who have BRAF V600E or BRAF V600K variants and may benefit from FDA-approved targeted therapies.

MDSpire News

August 07, 2026

FDA Approves Viral Therapy Plus Nivolumab

Accelerated approval is based on objective response rate and duration of response in advanced melanoma, with postapproval trials required to confirm clinical benefit.

MDSpire News

August 04, 2026

Distribution Barriers May Reduce Biologic Drug Survival

A real‐world Brazilian registry suggests that challenges in biologic distribution were associated with treatment interruption, particularly among therapies requiring more frequent dosing.

MDSpire News

July 30, 2026

Daily Itch Duration Linked to Quality-of-Life Burden

Daily itch duration emerged as the strongest factor linking disease severity with quality of life, ahead of sleep disturbance, scratching frequency, and average itch intensity.

MDSpire News

July 29, 2026

Medical Oddities: Tattoo Regret Meets Nanotech

This week is about smart tattoos, social clues, pool perks, and tea's surprising brain connection.

MDSpire News

July 22, 2026

Ixekizumab May Improve Early Response After Secukinumab Failure

A real-world cohort found faster early skin responses with ixekizumab than with guselkumab or ustekinumab following secukinumab treatment failure, while all three biologics demonstrated favorable safety.

MDSpire News

July 17, 2026

PRP May Offer the Strongest Hair Transplant Evidence

Structured review highlights stronger evidence for platelet-rich plasma than for exosome-based and other emerging regenerative therapies while underscoring the need for standardized transplantation-specific research.

MDSpire News